[1]Beger HG, Warshaw AL, Büchler MW, et al.The Pancreas[M].Oxford:Blackwell Science, 1998∶587-593.
|
[2]张臣烈, 张圣道.急性坏死性胰腺炎的外科治疗[J].临床外科杂志, 1993, 1 (2) ∶6-8.
|
[3]张圣道.规则性胰腺切除术治疗急性坏死性胰腺炎[J].中华外科杂志, 1985, 23 (12) ∶717-718.
|
[4]汤耀卿, 张圣道, 张臣烈, 等.急性坏死性胰腺炎加强监护的探讨[J].实用外科杂志, 1992, 12 (12) ∶635-636.
|
[5]雷若庆, 吴旭波, 田锐, 等.暴发性急性胰腺炎的外科治疗策略探讨[J].外科理论与实践, 2005, 10 (1) ∶56-60.
|
[6]中华医学会外科学分会胰腺外科学组.重症急性胰腺炎诊治指南[J].中华外科杂志, 2007, 45 (11) ∶727-729.
|
[7]Greer SE, Burchard KW.Acute pancreatitis and critical illness:apancreatic tale of hypoperfusion and inflammation[J].Chest, 2009, 136 (5) ∶1413-1419.
|
[8]Payen D, de Pont AC, Sakr Y, et al.A Positive Fluid Balance is As-sociated with a Worse Outcome in Patients with Acute RenalFailure[J].Crit Care, 2008, 12 (3) ∶R74.
|
[9]Bouchard J, Soroko SB, Chertow GM, et al.Fluid accumulation, sur-vival and recovery of kidney function in critically ill patients with a-cute kidney injury[J].Kidney lnt, 2009, 76 (4) ∶422-427.
|
[1] | Xinyu MA, Tingting DUAN, Jingya XU, Jiahe ZHAO, Chunlei ZHANG, Baolong LI. Research advances in the protective effect of sulforaphane against liver injury and related mechanisms[J]. Journal of Clinical Hepatology, 2022, 38(1): 206-209. doi: 10.3969/j.issn.1001-5256.2022.01.036 |
[2] | Wenqian XU, Min GUO, Xiao WANG, Yaoqi WU, Jinyuan ZHANG, Heguo LI. Molecular mechanism of liver injury in acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2663-2668. doi: 10.3969/j.issn.1001-5256.2022.11.045 |
[3] | Yan YANG, Feilin GE, Qian HUANG, Rui ZENG, Xinyue ZHANG, Qin SUN. Risk factors for herb-induced liver injury[J]. Journal of Clinical Hepatology, 2022, 38(5): 1183-1187. doi: 10.3969/j.issn.1001-5256.2022.05.044 |
[4] | Qian YU, Sai ZHAO, Liangming LIU. Macrophage depletion and its application in liver injury[J]. Journal of Clinical Hepatology, 2022, 38(12): 2859-2863. doi: 10.3969/j.issn.1001-5256.2022.12.034 |
[5] | Liu LiMin, Yao MingJie, Hu DuanMin. Research advances in Akkermansia muciniphila and liver injury[J]. Journal of Clinical Hepatology, 2020, 36(9): 2133-2136. doi: 10.3969/j.issn.1001-5256.2020.09.051 |
[6] | HE TingTing, ZHOU GuangDe, LIU ShuHong, ZHOU Chao, ZHU Li, ZHANG Ning, WANG Yan, XIAO XiaoHe, GONG Man. Clinical characteristics of liver injury induced by environmental toxins:An analysis of 8 cases[J]. Journal of Clinical Hepatology, 2020, 36(11): 2530-2533. doi: 10.3969/j.issn.1001-5256.2020.11.027 |
[7] | HUANG Qing, LI JingTao, LIU YongGang, WEI HaiLiang, YAN ShuGuang, GUO YingJun, CHANG ZhanJie. Regulatory effect of mTOR pathway-mediated autophagy in liver injury[J]. Journal of Clinical Hepatology, 2020, 36(11): 2621-2625. doi: 10.3969/j.issn.1001-5256.2020.11.051 |
[8] | Gong Hang, Huang Zhong, Liu XianLi. Clinical features and pathogenesis of liver injury caused by SARS,MERS and COVID-19[J]. Journal of Clinical Hepatology, 2020, 36(8): 1887-1890. doi: 10.3969/j.issn.1001-5256.2020.08.046 |
[9] | Zhou YaNing, Feng Gong, Liu ManLing, Yan QinQin, Fan LiPing, Mi Man. Current status of the research on liver injury caused by SARS-CoV-2[J]. Journal of Clinical Hepatology, 2020, 36(6): 1402-1406. doi: 10.3969/j.issn.1001-5256.2020.06.047 |
[10] | Branch of Hepatobiliary Diseases, China Association of Chinese Medicine, Branch of Chinese Patent Medicine, China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(5): 835-843. doi: 10.3969/j.issn.1001-5256.2016.05.003 |
[11] | Yin Fei. Paracetamol-induced liver injury in patients with chronic alcoholism: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(11): 1904-1905. doi: 10.3969/j.issn.1001-5256.2015.11.035 |
[12] | Jiang PingPing, Zhang Quan, Wang YuPing, Wang Hui, Cheng MingLiang. Preventive effects of blueberry on hepatic injury by downregulating the expression of TLR4[J]. Journal of Clinical Hepatology, 2012, 28(5): 380-382+394. |
[13] | Qu ZhongXing, Zhao Ye, Li JianSheng. Trichloroethylene poisoning mainly leading to hepatic injury:a case report[J]. Journal of Clinical Hepatology, 2012, 28(3): 232-233. |
[14] | Nai Chao, Yu CongHui, Yu ChangZhong, Shi ZhiYuan. In vitro study of hepatocyte growth factor in inducing Wharton′s jelly-derived mesenchymal stem cells into hepatocyte-like cells[J]. Journal of Clinical Hepatology, 2012, 28(2): 139-143. |
[15] | Feng Fei, Ma Li, Cui HongLing, Liu JingFang. The Adefovir dipivoxil presses the liver cell growth hormone treatment chronic type B heavy hepatitis curative effect observation jointly[J]. Journal of Clinical Hepatology, 2010, 26(6): 594-595. |
[16] | Wang JiPing, Leng JiYan, Dong Dong, Yan WeiQun. The protective effect of rhKD/APP on liver injured by D-galactosamine in rats[J]. Journal of Clinical Hepatology, 2007, 23(1): 24-25. |
[17] | Bai Yu, Cao ZhiChen, Liu JinXing, Li BingShun, Yang XueNong, Li FengLin. The effect of the iron metabolism abnormality on the hepatocytes damage of hepatitis B[J]. Journal of Clinical Hepatology, 2001, 17(1): 25-27+23. |